COMPARISON OF FLUCONAZOLE AND KETOCONAZOLE FOR OROPHARYNGEAL CANDIDIASIS IN AIDS
- 8 April 1989
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 333 (8641), 746-748
- https://doi.org/10.1016/s0140-6736(89)92572-5
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Gastropathy and Ketoconazole Malabsorption in the Acquired Immunodeficiency Syndrome (AIDS)Annals of Internal Medicine, 1988
- Treatment of systemic fungal infections: Recent progress and current problemsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- Treatment of Infections Associated with Human Immunodeficiency VirusNew England Journal of Medicine, 1988
- Cryptococcal Meningitis in the Acquired Immunodeficiency Syndrome (AIDS): Successful Treatment with Fluconazole after Failure of Amphotericin BAnnals of Internal Medicine, 1988
- Cryptococcal Meningitis and FluconazoleAnnals of Internal Medicine, 1987
- Antifungal effects of fluconazole (UK 49858), a new triazole antifungal, in vitroJournal of Antimicrobial Chemotherapy, 1986
- Activity of fluconazole (UK 49,858) and ketoconazole against Candida albicans in vitro and in vivoAntimicrobial Agents and Chemotherapy, 1986
- Ketoconazole-resistant Candida esophagitis in patients with acquired immunodeficiency syndromeGastroenterology, 1986
- Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in miceAntimicrobial Agents and Chemotherapy, 1985
- Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humansAntimicrobial Agents and Chemotherapy, 1985